Sign In
Buy CYTH
$0.721
+0 (+0%)
At Close: Jun 25, 2025
Cyclo Therapeutics Provides Business Update and Reports First Quarter 2021 Financial Results
09:05am, Monday, 17'th May 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Cyclo Therapeutics Appoints Lori McKenna Gorski as Global Head of Patient Advocacy
09:05am, Tuesday, 11'th May 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Anavex, Cyclo Therapeutics, And Green Valley: Stalling The Progression Of Alzheimer's Disease
04:02am, Wednesday, 28'th Apr 2021
Alzheimer's disease can largely be stabilized if one inhibits the formation of peroxynitrite, removes it, and partially reverses the damage that it does to the brain through oxidation and nitration. A
Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
09:05am, Tuesday, 27'th Apr 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Cyclo Therapeutics to Proceed with IND Filing for Phase 2 Trial Using Intravenous Trappsol® Cyclo™ in Alzheimer's Disease
09:25am, Tuesday, 20'th Apr 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
7 Beaten Down Stocks with Significant Insider Buying
02:16pm, Friday, 09'th Apr 2021
Insider buying could be a bullish sign for a stock. Insiders may sell their shares for many reasons.
CYTH Stock Price Increases Over 10% Pre-Market: Why It Happened
09:04am, Thursday, 25'th Mar 2021
The stock price of Cyclo Therapeutics Inc (NASDAQ: CYTH) has increased by over 10% pre-market. This is why it happened.
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Cyclo Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
08:05am, Monday, 15'th Mar 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Cyclo Therapeutics to Participate in Inaugural Emerging Growth Virtual Conference
08:05am, Friday, 12'th Mar 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
Cyclo Therapeutics Appoints Russ Belden as Acting Chief Commercial Officer
08:35am, Wednesday, 10'th Mar 2021
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company dedicated to developing life-changin
GAINESVILLE, Fla.--(BUSINESS WIRE)--Cyclo Therapeutics, Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a clinical stage biotechnology company developing cyclodextrin-based produc
7 Stocks With Insider Buying
03:34pm, Friday, 05'th Feb 2021
Insider buying could be a bullish signal for a stock. Why? The insiders may sell for a number of reasons.
Why Cyclo, Vivos Therapeutics And More Are Moving Today
01:36pm, Tuesday, 05'th Jan 2021
Cyclo Therapeutics (NASDAQ: CYTH) shares are trading higher Tuesday after the company announced "positive" efficacy data from an extension protocol with Trappsol Cyclo in patients with Niemann-Pick D
